Literature DB >> 11245914

NSAIDs bound to methacrylic carriers: microstructural characterization and in vitro release analysis.

A Gallardo1, C Parejo, J San Román.   

Abstract

Chemically controlled drug delivery systems or 'polymeric drugs' based on copolymers of 2-hydroxyethyl methacrylate, HEMA, and five methacrylic derivatives which incorporate ibuprofen or ketoprofen in their chemical structure by means of labile ester bonds, MAI, MAK, MAEK, MEI and MEK, have been prepared by free radical polymerization in solution at 50 degrees C. Three different spacers have been incorporated to the monomer structure: an aromatic amide, an aliphatic ester and a combined aromatic amide/aliphatic ester. Copolymerization reactions of the methacrylamide derivatives with HEMA follow the terminal model with reactivity ratio values, determined by the Tidwell and Mortimer (J. Polym. Sci. A 1965;3:369-378) non-linear least-squares treatment, of r(MAI)=0.38, r(HEMA)=1.69; r(MAK)=0.30, r(HEMA)=0.48; and r(MAEK)=0.66, r(HEMA)=2.85. From these values and considering that the methacrylates MEI and MEK are structurally related to HEMA, the microstructural analysis give us a random distribution of the monomeric units. The HEMA-rich copolymers, used for the in vitro experiments, showed a very high population of sequences with the active residue isolated by HEMA units. The in vitro release experiments were carried out at pH 7.4 and 9, using six different compositions for each copolymer system (1, 2.5, 5, 10, 20 and 30 wt% of the active acrylic monomer). The results show a controlled release in terms of weeks with very different profiles which depend on the type of spacer (the aromatic ester is more susceptible to hydrolysis than the aliphatic one), drug (ketoprofen release rate is higher than the ibuprofen one), composition of the copolymer (as a general rule, the release rate increases with the content of the attached drug until some composition where this effect is reverted because of the global increase in hydrophobicity) and pH (the release rate is noticeably higher in a strong basic medium, pH 9).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11245914     DOI: 10.1016/s0168-3659(01)00212-7

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  6 in total

1.  Enzymatic Polymerization of an Ibuprofen-Containing Monomer and Subsequent Drug Release.

Authors:  Nicholas D Stebbins; Weiling Yu; Kathryn E Uhrich
Journal:  Macromol Biosci       Date:  2015-04-16       Impact factor: 4.979

2.  Biodegradable polyesters containing ibuprofen and naproxen as pendant groups.

Authors:  Roselin Rosario-Meléndez; Weiling Yu; Kathryn E Uhrich
Journal:  Biomacromolecules       Date:  2013-09-06       Impact factor: 6.988

3.  In vivo assessment of parenteral formulations of oligo(3-hydroxybutyric Acid) conjugates with the model compound Ibuprofen.

Authors:  Pawel Stasiak; Malgorzata Sznitowska; Carsten Ehrhardt; Maria Luczyk-Juzwa; Pawel Grieb
Journal:  AAPS PharmSciTech       Date:  2010-11-19       Impact factor: 3.246

4.  Thermoresponsive P(HEMA-co-OEGMA) copolymers: synthesis, characteristics and solution behavior.

Authors:  Maciej Kasprów; Justyna Machnik; Łukasz Otulakowski; Andrzej Dworak; Barbara Trzebicka
Journal:  RSC Adv       Date:  2019-12-11       Impact factor: 4.036

5.  Aspirin-Based Organoiron Dendrimers as Promising Anti-Inflammatory, Anticancer, and Antimicrobial Drugs.

Authors:  Alaa S Abd-El-Aziz; Maysun R Benaaisha; Amani A Abdelghani; Rabin Bissessur; Laila H Abdel-Rahman; Ahmed M Fayez; Doaa Abou El-Ezz
Journal:  Biomolecules       Date:  2021-10-22

Review 6.  Covalent polymer-drug conjugates.

Authors:  Carlos Elvira; Alberto Gallardo; Julio San Roman; Alejandro Cifuentes
Journal:  Molecules       Date:  2005-01-31       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.